Keine Artikel in dieser Ansicht.


Stakeholder Discussions on: Innovation, availability and affordability of medical products. Can we achieve it all?

14.02.2018 | Veranstaltung

On 1 February 2018, we at the Swiss Federal Institute of Intellectual Property held discussions on innovation, availability and affordability of medical products with a variety of selected stakeholders. The panellists had discussions on how innovation can address various types of diseases and on what is needed to make sure, innovation will not only be available but also affordable for patients. For more information, please go to our landing page.


The news service platform IP-Watch published an article on the event: "Medicines Innovation and Access: Swiss Stimulate New Thinking". They mention this to be the first of a series of articles on ideas discussed at the event.